Food and Drug Administration to approve the pills for weight loss later this year
Because of this development, the FDA approved Rybelsus for adults with type 2 diabetes in 2019
Several Phase 3 trials cover type 2 diabetes (TRANSCEND-T2D), obstructive sleep apnea, MASLD, chronic kidney disease in patients with type 2 diabetes, knee osteoarthritis (TRIUMPH-4), and cardiovascular outcomes
Compare verified vendors on our best ipamorelin sources page, or browse all coupon codes for up to 50% off
The no-subscription model appeals to patients who want flexibility, but it also means less support infrastructure
In December 2025, the FDA approved a new Wegovy pill, also manufactured by Novo Nordisk, for weight loss treatment